|
Sensitivity analyses for measured blood loss ≥ 1000 ml (severe post-partum haemorrhage, or SPPH) |
||||||
| Assumed bias introduced in SPPH by unblinding due to shivering (mls) |
Group |
No. of women |
No. of cases |
% |
RR |
95% CI |
|
|
||||||
| 500 |
Misoprostol |
9214 |
295 |
3.2 |
1.23 |
(1.04 to 1.45) |
| Oxytocin |
9228 |
241 |
2.6 |
|||
| 400 |
Misoprostol |
9214 |
307 |
3.3 |
1.27 |
(1.07 to 1.49) |
| Oxytocin |
9228 |
243 |
2.6 |
|||
| 300 |
Misoprostol |
9214 |
313 |
3.4 |
1.29 |
(1.09 to 1.52) |
| Oxytocin |
9228 |
243 |
2.6 |
|||
| 200 |
Misoprostol |
9214 |
322 |
3.5 |
1.28 |
(1.09 to 1.51) |
| Oxytocin |
9228 |
251 |
2.7 |
|||
| 100 |
Misoprostol |
9214 |
334 |
3.6 |
1.31 |
(1.11 to 1.53) |
| Oxytocin |
9228 |
256 |
2.8 |
|||
| 0 |
Misoprostol |
9214 |
366 |
4.0 |
1.39 |
(1.19 to 1.63) |
| Oxytocin |
9228 |
263 |
2.9 |
|||
| -100 |
Misoprostol |
9214 |
401 |
4.4 |
1.50 |
(1.29 to 1.75) |
| Oxytocin |
9228 |
267 |
2.9 |
|||
| -200 |
Misoprostol |
9214 |
453 |
4.9 |
1.64 |
(1.41 to 1.90) |
| Oxytocin |
9228 |
277 |
3.0 |
|||
| -300 |
Misoprostol |
9214 |
499 |
5.42 |
1.74 |
(1.51 to 2.00) |
| Oxytocin |
9228 |
288 |
3.12 |
|||
| -400 |
Misoprostol |
9214 |
591 |
6.41 |
1.94 |
(1.70 to 2.22) |
| Oxytocin |
9228 |
305 |
3.31 |
|||
| -500 |
Misoprostol |
9214 |
688 |
7.47 |
2.10 |
(1.85 to 2.39) |
| Oxytocin |
9228 |
328 |
3.55 |
|||
Piaggio et al. BMC Medical Research Methodology 2003 3:19 doi:10.1186/1471-2288-3-19 |
||||||